MiR‐873 inhibition enhances gefitinib resistance in non‐small cell lung cancer cells by targeting glioma‐associated oncogene homolog 1

BACKGROUND: The five‐year survival rate of non‐small cell lung cancer (NSCLC) patients is very low. MiR‐873 is involved in the growth, metastasis, and differentiation of tumors. Herein, we determined the target gene and influence of miR‐873 in NSCLC. METHODS: MiRanda and Targetscan websites were use...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Shidai, He, Jing, Li, Jun, Guo, Renhua, Shu, Yongqian, Liu, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166090/
https://www.ncbi.nlm.nih.gov/pubmed/30126075
http://dx.doi.org/10.1111/1759-7714.12830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166090/
https://www.ncbi.nlm.nih.gov/pubmed/30126075
http://dx.doi.org/10.1111/1759-7714.12830

Ejemplares similares